Cargando…

Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts

INTRODUCTION: Drug–drug interaction (DDI) alerts in hospital electronic medication management (EMM) systems are generated at the point of prescribing to warn doctors about potential interactions in their patients’ medication orders. This project aims to determine the impact of DDI alerts on DDI rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Baysari, Melissa T, Zheng, Wu Yi, Li, Ling, Westbrook, Johanna, Day, Richard O, Hilmer, Sarah, Van Dort, Bethany Annemarie, Hargreaves, Andrew, Kennedy, Peter, Monaghan, Corey, Doherty, Paula, Draheim, Michael, Nair, Lucy, Samson, Ruby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701635/
https://www.ncbi.nlm.nih.gov/pubmed/31427312
http://dx.doi.org/10.1136/bmjopen-2018-026034
_version_ 1783445085254320128
author Baysari, Melissa T
Zheng, Wu Yi
Li, Ling
Westbrook, Johanna
Day, Richard O
Hilmer, Sarah
Van Dort, Bethany Annemarie
Hargreaves, Andrew
Kennedy, Peter
Monaghan, Corey
Doherty, Paula
Draheim, Michael
Nair, Lucy
Samson, Ruby
author_facet Baysari, Melissa T
Zheng, Wu Yi
Li, Ling
Westbrook, Johanna
Day, Richard O
Hilmer, Sarah
Van Dort, Bethany Annemarie
Hargreaves, Andrew
Kennedy, Peter
Monaghan, Corey
Doherty, Paula
Draheim, Michael
Nair, Lucy
Samson, Ruby
author_sort Baysari, Melissa T
collection PubMed
description INTRODUCTION: Drug–drug interaction (DDI) alerts in hospital electronic medication management (EMM) systems are generated at the point of prescribing to warn doctors about potential interactions in their patients’ medication orders. This project aims to determine the impact of DDI alerts on DDI rates and on patient harm in the inpatient setting. It also aims to identify barriers and facilitators to optimal use of alerts, quantify the alert burden posed to prescribers with implementation of DDI alerts and to develop algorithms to improve the specificity of DDI alerting systems. METHODS AND ANALYSIS: A controlled pre-post design will be used. Study sites include six major referral hospitals in two Australian states, New South Wales and Queensland. Three hospitals will act as control sites and will implement an EMM system without DDI alerts, and three as intervention sites with DDI alerts. The medical records of 280 patients admitted in the 6 months prior to and 6 months following implementation of the EMM system at each site (total 3360 patients) will be retrospectively reviewed by study pharmacists to identify potential DDIs, clinically relevant DDIs and associated patient harm. To identify barriers and facilitators to optimal use of alerts, 10–15 doctors working at each intervention hospital will take part in observations and interviews. Non-identifiable DDI alert data will be extracted from EMM systems 6–12 months after system implementation in order to quantify alert burden on prescribers. Finally, data collected from chart review and EMM systems will be linked with clinically relevant DDIs to inform the development of algorithms to trigger only clinically relevant DDI alerts in EMM systems. ETHICS AND DISSEMINATION: This research was approved by the Hunter New England Human Research Ethics Committee (18/02/21/4.07). Study results will be published in peer-reviewed journals and presented at local and international conferences and workshops.
format Online
Article
Text
id pubmed-6701635
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-67016352019-09-02 Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts Baysari, Melissa T Zheng, Wu Yi Li, Ling Westbrook, Johanna Day, Richard O Hilmer, Sarah Van Dort, Bethany Annemarie Hargreaves, Andrew Kennedy, Peter Monaghan, Corey Doherty, Paula Draheim, Michael Nair, Lucy Samson, Ruby BMJ Open Health Informatics INTRODUCTION: Drug–drug interaction (DDI) alerts in hospital electronic medication management (EMM) systems are generated at the point of prescribing to warn doctors about potential interactions in their patients’ medication orders. This project aims to determine the impact of DDI alerts on DDI rates and on patient harm in the inpatient setting. It also aims to identify barriers and facilitators to optimal use of alerts, quantify the alert burden posed to prescribers with implementation of DDI alerts and to develop algorithms to improve the specificity of DDI alerting systems. METHODS AND ANALYSIS: A controlled pre-post design will be used. Study sites include six major referral hospitals in two Australian states, New South Wales and Queensland. Three hospitals will act as control sites and will implement an EMM system without DDI alerts, and three as intervention sites with DDI alerts. The medical records of 280 patients admitted in the 6 months prior to and 6 months following implementation of the EMM system at each site (total 3360 patients) will be retrospectively reviewed by study pharmacists to identify potential DDIs, clinically relevant DDIs and associated patient harm. To identify barriers and facilitators to optimal use of alerts, 10–15 doctors working at each intervention hospital will take part in observations and interviews. Non-identifiable DDI alert data will be extracted from EMM systems 6–12 months after system implementation in order to quantify alert burden on prescribers. Finally, data collected from chart review and EMM systems will be linked with clinically relevant DDIs to inform the development of algorithms to trigger only clinically relevant DDI alerts in EMM systems. ETHICS AND DISSEMINATION: This research was approved by the Hunter New England Human Research Ethics Committee (18/02/21/4.07). Study results will be published in peer-reviewed journals and presented at local and international conferences and workshops. BMJ Publishing Group 2019-08-18 /pmc/articles/PMC6701635/ /pubmed/31427312 http://dx.doi.org/10.1136/bmjopen-2018-026034 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Health Informatics
Baysari, Melissa T
Zheng, Wu Yi
Li, Ling
Westbrook, Johanna
Day, Richard O
Hilmer, Sarah
Van Dort, Bethany Annemarie
Hargreaves, Andrew
Kennedy, Peter
Monaghan, Corey
Doherty, Paula
Draheim, Michael
Nair, Lucy
Samson, Ruby
Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title_full Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title_fullStr Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title_full_unstemmed Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title_short Optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
title_sort optimising computerised decision support to transform medication safety and reduce prescriber burden: study protocol for a mixed-methods evaluation of drug–drug interaction alerts
topic Health Informatics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6701635/
https://www.ncbi.nlm.nih.gov/pubmed/31427312
http://dx.doi.org/10.1136/bmjopen-2018-026034
work_keys_str_mv AT baysarimelissat optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT zhengwuyi optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT liling optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT westbrookjohanna optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT dayrichardo optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT hilmersarah optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT vandortbethanyannemarie optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT hargreavesandrew optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT kennedypeter optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT monaghancorey optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT dohertypaula optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT draheimmichael optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT nairlucy optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts
AT samsonruby optimisingcomputeriseddecisionsupporttotransformmedicationsafetyandreduceprescriberburdenstudyprotocolforamixedmethodsevaluationofdrugdruginteractionalerts